National Path Lab

Pregnancy & Reproductive Risk

Pregnancy and reproductive risk refers to factors that may affect a person's ability to conceive, carry a pregnancy safely to term, or have a baby without an increased chance of a specific health condition. This spans preconception planning, fertility evaluation, and risk assessment during pregnancy itself.

Many reproductive risks — infertility factors, chromosomal risk, carrier status for inherited conditions — can be identified before conception or early in pregnancy, allowing time for informed decisions and, where appropriate, medical intervention.

At National Path Lab (NPL), a comprehensive range of fertility, prenatal, and genetic testing is available to support reproductive risk assessment at every stage.

Tests Available at NPL

TORCH PCR

Turn Around Time
SAMPLE DAILY BY 8:00 PM, REPORT AFTER 7-10 DAYS

Rs. 15000

View DetailBook Now

MATERNAL BLOOD FOR FETAL DNA / NIPT ADVANCED

Turn Around Time
SAMPLE DAILY BY 4:00 PM, REPORT AFTER 12 WORKING DAYS

Rs. 32000

View DetailBook Now

ANTI MULLERIAN HORMONE; AMH

Turn Around Time
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY

Rs. 4000

View DetailBook Now

MATERNAL SERUM SCREENING; DUAL TEST,

Turn Around Time
SAMPLE DAILY BY 2:00 PM REPORT NEXT DAY EVENING

Rs. 4000

View DetailBook Now

MATERNAL SERUM SCREENING; QUADRUPLE TEST

Turn Around Time
SAMPLE DAILY BY 2:00 PM REPORT NEXT DAY EVENING

Rs. 6000

View DetailBook Now

FSH & LH STIMULATION BY GONADOTROPIN RELEASING HORMONE (GNRH)

Turn Around Time
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY

Rs. 14000

View DetailBook Now

THYROID PROFILE FREE

Turn Around Time
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY

Rs. 1000

View DetailBook Now

About Pregnancy & Reproductive Risk

Who Is at Risk?

Reproductive risk is influenced by a combination of factors relevant before and during pregnancy:

Non-Modifiable Factors

Modifiable Factors

  • Advanced maternal age (particularly from age 35), or advanced paternal age

  • Chronic conditions such as diabetes, thyroid disease, or hypertension — better control before and during pregnancy reduces risk

  • Family history of genetic or chromosomal conditions

  • Obesity

  • Previous pregnancy complications or pregnancy loss

  • Smoking, alcohol use, and certain medication exposures

  • Ethnic background associated with higher carrier frequency for certain inherited conditions

  • Untreated infections relevant to pregnancy

  • Consanguinity (blood relationship between partners)

Warning Signs You Shouldn't Ignore

  • Irregular periods or difficulty conceiving after 12 months of trying (6 months if 35 or older)

  • Two or more pregnancy losses

  •   Abnormal bleeding during pregnancy

  • Severe swelling or high blood pressure during pregnancy

  • Known family history of a genetic or chromosomal condition

  • A previous child affected by a genetic condition

Test

Clinical Relevance

AMH, FSH, LH (Fertility Hormones)

Assess ovarian reserve and reproductive hormone status.

Genetic Carrier Screening

Identifies carrier status for inherited conditions relevant to future pregnancies.

Prenatal Screening (NIPT Test)

Estimates risk of common chromosomal conditions during pregnancy.

Dual Test

 

Quadruple Test

 

Recurrent Pregnancy Loss Panel

Investigates possible causes after repeated pregnancy loss.

Thyroid Function Tests

Thyroid dysfunction is a treatable contributor to fertility and pregnancy complications.

TORCH / Congenital Infection Panel

Screens for selected infections relevant to pregnancy.

Related Packages

ANC CHECKUP PACKAGE – PREGNANCY CARE PACKAGE (BASIC)

Test Includes
14 Tests

Rs. 3000

View DetailBook Now

ANC CHECKUP PACKAGE – PREGNANCY CARE PACKAGE (ADVANCED)

Test Includes
15 Tests

Rs. 7000

View DetailBook Now

Frequently Asked Questions

Ideally before conception — preconception testing allows the most time to understand results and make informed decisions, though many tests remain valuable during early pregnancy as well.
Yes, several reproductive hormone tests (such as FSH and LH) need to be drawn on a specific day of the menstrual cycle for accurate interpretation — your doctor will advise on correct timing.
No. Screening tests (like NIPT or the dual test) estimate risk; they do not confirm a diagnosis. A high-risk screening result is typically followed by diagnostic testing and genetic counselling.
Generally yes — risk to a pregnancy depends on both partners' carrier status for the same condition, so testing both (or the second partner if the first screens positive) is usually most informative.
Yes, in many cases — through preconception planning, managing chronic conditions before pregnancy, genetic counselling, and appropriate prenatal care and monitoring.